Somatostatin Receptor Type 2 Antagonism Improves Glucagon Counter regulatory Response to Hypoglycemia in Type 1 Diabetes BB Rats

被引：0
|
作者：
Qin, Tairan
Karimian, Negar
Osundiji, Mayowa
Huang, Yachi
Coy, David H.
Vranic, Mladen
Gaisano, Herbert Y.
机构：
来源：
DIABETES | 2012年 / 61卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
176-OR
引用
收藏
页码：A47 / A47
页数：1
相关论文
共 50 条
  • [41] ZT-01, a somatostatin receptor 2 antagonist, increases glucagon response to hypoglycaemia in a phase 1b glycaemic clamp study in type 1 diabetes
    Abitbol, A.
    Liggins, R.
    Peers, S.
    Simonson, E.
    Riddell, M. C.
    Midmer, M.
    DIABETOLOGIA, 2023, 66 (SUPPL 1) : S34 - S34
  • [42] Opioid Receptor Blockade Improves Hypoglycemia-Associated Autonomic Failure in Type 1 Diabetes Mellitus
    Vele, Septimiu
    Milman, Sofiya
    Shamoon, Harry
    Gabriely, Ilan
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2011, 96 (11): : 3424 - 3431
  • [43] Opiate Blockade Promotes Counter-Regulatory Responses to Hypoglycemia in Patients With Type 1 Diabetes (T1DM)
    Naik, Sarita
    De Aguiar, Renata Belfort
    Sherwin, Robert S.
    DIABETES, 2013, 62 : A59 - A59
  • [44] Effects of somatostatin receptor type 2 antagonism during insulin-induced hypoglycaemia in male rats with prediabetes
    Hoffman, Emily G.
    D'Souza, Ninoschka C.
    Aiken, Julian
    Atherley, Sara
    Liggins, Richard
    Riddell, Michael C.
    DIABETES OBESITY & METABOLISM, 2023, 25 (06): : 1547 - 1556
  • [45] Vildagliptin Reduces Glucagon during Hyperglycemia and Sustains Glucagon Counterregulation during Hypoglycemia in Type 1 Diabetes
    Farngren, Johan
    Persson, Margaretha
    Schweizer, Anja
    Foley, James E.
    Ahren, Bo
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2012, 97 (10): : 3799 - 3806
  • [46] Nasal glucagon: a viable alternative to treat insulin-induced hypoglycemia in Japanese patients with type 1 and type 2 diabetes
    Matsuhisa, Munehide
    Nagashima, Hirotaka
    Takita, Yasushi
    Nasu, Risa
    Ohwaki, Kenji
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2019, 35
  • [47] Nasal Glucagon: A Viable Alternative to Treat Insulin-Induced Hypoglycemia in Japanese Patients with Type 1 and Type 2 Diabetes
    Matsuhisa, Munehide
    Takita, Yasushi
    Nasu, Risa
    Ohwaki, Kenji
    Nagashima, Hirotaka
    DIABETES, 2019, 68
  • [48] Glucagon Use by US Adults with Type 1 and Type 2 Diabetes
    Kahn, Peter
    Liu, Shuling
    McCoy, Rozalina G.
    Gabbay, Robert A.
    Lipska, Kasia J.
    DIABETES, 2020, 69
  • [49] Glucagon use by US adults with type 1 and type 2 diabetes
    Kahn, Peter A.
    Liu, Shuling
    McCoy, Rozalina
    Gabbay, Robert A.
    Lipska, Kasia
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2021, 35 (05)
  • [50] Glucagon receptor antagonists for the treatment of type 2 diabetes.
    Handlon, AL
    Akwabi-ameyaw, A
    Brown, K
    De Anda, F
    Drewry, D
    Fang, J
    Irsula, O
    Li, G
    Linn, JA
    Milliken, NO
    Ramanjulu, J
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2003, 226 : U31 - U31
12345